Acquired haemophilia A: a case report

Adam Stemplewski; Paulina Stemplewska; Paulina Gorzelak-Pabiś; Marlena Broncel

doi:10.5114/ms.2017.70350

eISSN: 2300-6722
ISSN: 1899-1874

Medical Studies/Studia Medyczne

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2017
vol. 33

Send email

Copy url:

abstract:

Case report

Acquired haemophilia A: a case report

Adam Stemplewski

¹

,

Paulina Stemplewska

¹

,

Paulina Gorzelak-Pabiś

¹

,

Marlena Broncel

¹

Department of Internal Diseases and Clinical Pharmacology, Medical University of Lodz, Lodz, Poland

Medical Studies/Studia Medyczne 2017; 33 (3): 227–231

DOI: https://doi.org/10.5114/ms.2017.70350

Online publish date: 2017/09/30

View full text Get citation

PlumX metrics:

Acquired haemophilia A is rare, autoimmune bleeding disorder caused by the production of autoantibodies against coagulation factor VIII (FVIII). The disorder affects 1.5 people per 1 million population a year, particularly the elderly. Unlike congenital haemophilia, the disease occurs in a similar proportion of men and women. An 86-year-old patient was admitted to the Department of Internal Medicine and Pharmacology with anaemia, progressive weakness, bruising in the subcutaneous tissue, and generaliesd stiffness of joints. Routine blood tests revealed isolated prolongation of activated partial thromboplastin time (aPTT) above 100 s. Activated partial thromboplastin time mixing test also showed prolongation of aPTT equal to 104.2 s. Factor VIII activity was 2%. The patient was referred to the Haematology Department, where a positive titre of anticoagulant 11 (BU) was obtained. After diagnosing acquired haemophilia A, the patient was administered activated prothrombin complex concentrate and prednisone, which resulted in clinical improvement and shortening of aPTT.

keywords:

Acquired haemophilia A: a case report

Adam Stemplewski 1 , Paulina Stemplewska 1 , Paulina Gorzelak-Pabiś 1 , Marlena Broncel 1

acquired haemophilia A, bleeding disorder, prolonged activated partial thromboplastin time, factor VIII

Adam Stemplewski

¹

,

Paulina Stemplewska

¹

,

Paulina Gorzelak-Pabiś

¹

,

Marlena Broncel

¹